INCR Earnings & Financial Statements
InterCure Ltd.
$5.03
-$0.10(-1.95%)
57
Overall
60
Value
66
Tech
47
Quality
Market Cap
$76.97M
Volume
3.26K
52W Range
$3.40 - $8.45
Target Price
$7.00
INCR earnings and financial statements: InterCure Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly.
INCR Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $270.20M | $238.84M | $355.55M | $388.68M | $219.68M |
| Cost of revenue | $237.02M | $221.53M | $250.98M | -$229.73M | $123.69M |
| Operating income | -$63.03M | -$93.27M | -$41.42M | $52.93M | $39.48M |
| EBITDA | -$24.11M | -$78.06M | - | $52.75M | $18.73M |
| Net income | -$35.71M | -$110.45M | -$77.39M | $87.50M | $24.26M |
| EPS (diluted) | $-0.66 | $-1.48 | $-1.36 | $0.99 | $0.11 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $690.55M | $762.57M | $762.57M | $958.01M | $686.32M |
| Total liabilities | $294.19M | $364.90M | $364.90M | $436.53M | $227.13M |
| Shareholders’ equity | $396.52M | $396.97M | $396.97M | $501.31M | $448.03M |
| Cash and equivalents | $46.47M | $78.32M | $94.82M | $40.00M | $193.21M |
| Long-term debt | $78.95M | $137.18M | $137.18M | $122.79M | $33.25M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $16.19M | -$66.93M | -$53.63M | $51.27M | $25.02M |
| Capital expenditure | - | - | - | -$19.74M | -$14.03M |
| Free cash flow | $15.07M | -$71.56M | -$56.25M | $31.52M | $10.99M |
| Dividends paid | -$11.00M | $98.0K | - | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCR | $5.03 | -1.9% | 3.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |